Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crespel & Deiters Group is a prominent European specialist in wheat-based functional ingredients, headquartered in Ibbenbüren, Germany. With a history dating back to 1858, the company processes wheat into high-quality starches and proteins for the food, pharmaceutical, and technical industries. In the life sciences sector, they are recognized for producing pharmaceutical-grade wheat starch that serves as an essential excipient, binder, and disintegrant in solid dosage forms. The group operates through several specialized subsidiaries, including Loryma, to deliver tailored solutions for plant-based nutrition and industrial applications. Their commitment to sustainability and innovation has made them a key partner for global manufacturers seeking natural, high-performance raw materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crespel & Deiters Group.